IHH Spearheads Cancer Care Leadership in Asia With Official Launch of Region’s First Private Proton Therapy Centre
Retrieved on:
Mercoledì, Maggio 15, 2024
Centre has already treated more than 100 patients from 16 countries, ranging in ages from 18 months to 85 years.
Key Points:
- Centre has already treated more than 100 patients from 16 countries, ranging in ages from 18 months to 85 years.
- SINGAPORE, May 15, 2024 (GLOBE NEWSWIRE) -- IHH Healthcare, a world-leading integrated healthcare provider, has reinforced its position as Asia’s leading cancer care provider with the official opening of the Mount Elizabeth Proton Therapy Centre in Singapore.
- Located in Mount Elizabeth Novena Hospital, the centre makes IHH the first private healthcare provider in the region and in Singapore to offer proton therapy, providing patients unprecedented access to this advanced and highly specialised cancer treatment.
- IHH Healthcare Singapore’s investment in proton therapy demonstrates our unwavering resolve to provide our patients with the best care,” said Dr Peter Chow, Chief Executive Officer, IHH Healthcare Singapore.